CPNCs - Nerve Soothe Cruise
- Definition: Catheters near peripheral nerves for continuous local anesthetic (LA) infusion, providing targeted pain relief.
- Benefits: 📌 POMS for CPNC perks!
- Prolonged analgesia (often 2-5 days).
- Opioid-sparing, reducing side effects.
- Mobilization enhanced, faster recovery.
- Satisfaction increased.
- Key Indications:
- Major limb surgeries (total knee/shoulder).
- Significant trauma (rib/femoral fractures).
- Phantom limb pain management.
- Technique Highlights:
- Ultrasound guidance for precise placement.
- LAs: Ropivacaine (0.2%), Bupivacaine (0.125%).
- Infusion: Basal rate + Patient-Controlled Epidural Analgesia (PCEA) boluses.
⭐ CPNCs effectively reduce chronic post-surgical pain (CPSP) risk, especially after major joint arthroplasty.
CPNCs: Insertion & Infusions - Probes & Potions
-
Probes: Insertion Techniques & Equipment
- Guidance: Ultrasound (USG) is standard (in-plane or out-of-plane views). Nerve stimulator as adjunct for confirmation (motor response at <0.5mA).
- Catheters: Stimulating (confirm proximity before LA) vs. Non-stimulating. Multi-orifice preferred.
- Techniques: Seldinger (guidewire) or Catheter-over-needle. Tunneling (2-5 cm from insertion) reduces dislodgement & infection.
-
Potions: Infusion Strategies
- Local Anesthetics (LAs): Dilute, long-acting agents.
- Ropivacaine: 0.1-0.2%
- Bupivacaine/Levobupivacaine: 0.0625-0.125%
- Regimens:
- Continuous Basal Infusion (CBI): 4-8 mL/hr.
- Patient-Controlled Regional Analgesia (PCRA): Bolus 3-5 mL, lockout 20-60 min.
- Programmed Intermittent Bolus (PIB): e.g., 5-10 mL every 1-2 hrs; may offer better spread.
- Adjuvants: Limited role in continuous infusions; focus on LA selection & concentration.
- Local Anesthetics (LAs): Dilute, long-acting agents.
⭐ Catheter tip to nerve distance is critical; US-guided hydrodissection with LA or saline confirms perineural spread before full bolus or infusion initiation for optimal analgesia and safety.
CPNCs: Monitoring & Mayhem - Guarding & Gotchas
- Vigilant Monitoring:
- Assess pain (VAS/NRS), sensory/motor block levels (e.g., Bromage scale for lower limb) q4-8h.
- Catheter site: Inspect for leakage, dislodgement, kinking, signs of infection (erythema, warmth, tenderness, pus).
- Pump function: Confirm correct LA, rate, volume infused, battery.
- Patient education: Report pain, numbness changes, pump alarms. Ambulation safety.
- Gotchas & Guarding (Complications):
- Catheter Issues:
- Migration/Dislodgement: ↓ analgesia. Secure well.
- Leakage: Common. Adjust dressing; may need resiting.
- Occlusion: Pump alarm. Gentle flush; avoid high pressure.
- Block Issues:
- Inadequate analgesia: Check system. Consider rescue bolus (e.g., 5-10ml of dilute LA) or adjuncts.
- Unintended spread (e.g., phrenic nerve palsy with interscalene).
- Infection: Strict asepsis. Remove catheter if suspected.
- ⚠️ LAST: Rare with dilute infusions. Early signs: tinnitus, metallic taste, perioral numbness. Late: seizures, arrhythmias. Management: Intralipid 20% (Bolus $1.5$ ml/kg, then infusion $0.25$ ml/kg/min).
- Nerve Injury: Persistent paresthesia/deficit. Stop infusion, investigate.
- ⭐ > Compartment syndrome can be masked by effective analgesia. Maintain high index of suspicion for pain out of proportion, especially in trauma or tight casts.
- Catheter Issues:
High‑Yield Points - ⚡ Biggest Takeaways
- Continuous Peripheral Nerve Catheters (CPNCs) offer prolonged postoperative analgesia, reducing opioid consumption.
- Key sites include femoral, interscalene, sciatic, and popliteal nerves.
- Ultrasound guidance is crucial for accurate placement and minimizing complications.
- Major risks: catheter-related infection and Local Anesthetic Systemic Toxicity (LAST).
- Regular monitoring for block effectiveness, catheter dislodgement, and neurovascular status is essential.
- Particularly beneficial for major joint replacements and ambulatory pain management strategies.
Continue reading on Oncourse
Sign up for free to access the full lesson, plus unlimited questions, flashcards, AI-powered notes, and more.
CONTINUE READING — FREEor get the app
